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The effect of the phorbol ester 12-0-tetrad~onyl-phorbol-13-a~tate (TPA) on noradrenaline (NA) and 
acetylcholine (ACh)-evoked amylase secretion in isolated segments of rat pancreas was investigated. TPA 
alone evoked a relatively small increase in amylase output. However, when combined with either noradrena- 
line or ACh, the phorbol ester markedly enhanced the secretagogue-induced amylase secretion. These effects 
were dose related. TPA also enhanced the amylase secretion evoked by either the CaZf ionophore A23187 
or dibutyryl cyclic AMP. This potentiation by TPA of noradrenaline, ACh, Ca2+ ionophore A23187 and 
dibutyryl cyclic AMP-evoked amylase output may suggest he existence of a third pathway controlling en- 
zyme secretion in the pancreas. 
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1. INTRODUCTION 
Enzyme secretion in the exocrine pancreas is 
regulated by secretagogues which act via two dif- 
ferent stimulus-secretion coupling mechanisms. 
One pathway is activated by secretin, vasoactive 
intestinal polypeptide (VIP), cholera toxin and 
catecholamines resulting in an increase in en- 
dogenous adenosine 3 ’ ,5 ’ -cyclic monophosphate 
(cyclic AMP). The other pathway is stimulated by 
ACh, cholecystokinin (CCK-like and bombesin- 
like peptides and involves changes in membrane 
potential, release of cellular Ca2+ and an elevation 
in intracellular guanosine 3 ’ ,5 ’ -cyclic monophos- 
phate (cyclic GMP) [l-5]. Two secretagogues (e.g., 
VIP and ACh) acting via the two different path- 
ways can potentiate one another whereas two 
secretagoguges (e.g., ACh and CCK) acting 
through the same mechanism cannot [6]. 
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Recently, several studies have demonstrated that 
TPA can markedly stimulate enzyme output in the 
pancreas without affecting either Ca2+ or cyclic 
nucleotide metabolism [7-g]. There are some sug- 
gestions that TPA may exert its effect on enzyme 
secretion through activation of protein kinase C 
[lo-l 31. Since TPA cannot stimulate either cellular 
Ca2+ release or cyclic AMP metabolism then it 
might act to potentiate enzyme secretion evoked 
either by hormones and neurotransmitters which 
are known to elevate cytoplasmic Ca2+ and cyclic 
AMP or by agents which can artificially elevate in- 
tracellular Ca2+ and cyclic AMP. It has been 
shown that TPA can potentiate the enzyme secre- 
tion induced by the Ca2* ionophore A23187 1111, 
a substance which is known to increase cytoplasmic 
Ca*+ [14]. 
The present study was designed mainly to in- 
vestigate whether TPA can also enhance the en- 
zyme secretion evoked by agents which can elevate 
endogenous cyclic AMP. Furthermore, the effect 
of TPA on the acetylcholine and A23187-induced 
amylase secretion was examined for comparison. 
~~bIis~ed by Elsevier Science ~ubI~~ers B. K ~Bio~ed~caI Division) 
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2. METHODS 
All experiments were performed on isolated 
segments of rat pancreas. Adult animals were 
killed by a blow to the head and the pancreas was 
quickly removed and placed in a modified Krebs- 
Henseleit solution of the following composition 
(mM): NaCl103, KC1 4.7, CaC12 2.56, MgC12 1.13, 
NaHC03 25, NaHzP04 1.15, D-glucose 2.8, Na 
pyruvate 4.9, Na fumarate 2.7 and Na glutamate 
4.9. The solution was gassed with 95% 02/5% 
CO2 and maintained at 37°C. 
TPA 10-5~ 
1.0 unit ml -1 
(100 mg tirrue)‘1 r 
O- 
The rat pancreas was cut into small segments 
(3-5 mg) and a total weight of about 300 mg was 
placed in a perspex flow chamber and superfused 
with Krebs-Henseleit solution at a flow rate of 1 
ml.min-‘. The amylase concentration in the ef- 
fluent from the chamber was measured using an 
on-line fluorometric assay by the methods des- 
cribed in [15,16]. Throughout an experiment he 
generation of fluorescence, which is a linear func- 
tion of amylase concentration, was continuously 
monitored on a pen recorder. The secretagogue- 
evoked amylase release (i.e., that above basal out- 
put) was routinely expressed in terms of the output 
at the peak of the response in units. ml-’ (100 mg 
tissue)-‘. One unit of amylase is defined as the 
amount which will liberate 1 .O mg of maltose from 
starch in 3 min at pH 6.9 and 20°C. In this study 
of a-amylase (Sigma type IIA) was used as a stan- 
dard for calibration. TPA, noradrenaline, ACh, 
Ca2+ ionophore A23187 and dibutyryl cyclic AMP 
(Sigma) were added directly to the superfusing 
solution in known concentrations. 
: 
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Fig.1. (A) Effects of lo-’ M TPA on amylase secretion 
from superfused rat pancreatic fragments. The horizon- 
tal bar indicates the duration of TPA stimulation. Ver- 
tical calibration: 1.0 unit + ml-’ . (100 mg tissue)-‘. In 
this and fig.2-4 the horizontal line labelled 0 represents 
the fluorescence reading without pancreatic tissue in the 
flow chamber. (B) Dose-response curve showing the ef- 
fect of TPA (lo-* - lo-’ M) on amylase secretion. Each 
point is mean f SE, n is indicated by the numbers beside 
each mean point. 
3. RESULTS 
10m6 M evoked relatively small increases (0.43 * 
0.02-0.18 & 0.01 unit. ml-’ . (100 mg tissue)-‘) in 
amylase secretion. 
The mean (of: SE) basal output of amylase from Fig.2A shows an original chart recording of 
superfused segments of rat pancreas was 2.93 + 
0.11 unit-ml-’ - (100 mg tissue)-‘, n = 54. Fig.1 
amylase output from an individual experiment 
following superfusion of rat pancreatic fragments 
shows an original chart recording of the response with 10e7 M noradrenaline in the absence (a) and 
produced by superfusing a preparation with lo-’ presence (b) of low6 M TPA. Exposure of pan- 
M TPA. The phorbol ester evoked a relatively slow creatic segments to 10e7 M noradrenaline resulted 
increase in amylase output reaching a maximum in a mean (+ SE) peak amylase secretion of 0.62 f 
after 25-30 min and then gradually declining to a 0.02 unit *ml-’ .(lOO mg tissue)-‘, n = 6. In the 
lower level. The peak amylase secretion above 
basal level was 1.45 +0.08 unit. ml-‘. (100 mg 
presence of 10e6 M TPA the noradrenaline-induced 
amylase secretion increased to 2.10+0.13 
tissue)-‘, n = 9. Fig. 1B shows the effect of varying 
the concentrations (10-8-10-’ M) of TPA on 
unit. ml-’ . (100 mg tissue)-‘, n = 6. These effects 
of noradrenaline were dose related. Fig.ZB shows 
amylase output. Concentrations between lo-* and dose response curves for the noradrenaline-elicited 
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Fig.2. (A) Effects of IO-’ M noradrenaline (NA) on 
amylase output from superfused rat pancreatic segments 
in the absence (a) and presence (b) of 10e6 M TPA. The 
responses (a) and (b) are continuous fluorescence inten- 
sity from a singIe experiment. The horizontal bars in- 
dicate the duration of stimulation. Vertical calibration: 
2.0 units. ml-’ . (100 mg tissue))‘. (B) Dose-response 
curves showing the effect of differing concentrations of 
noradrenaline (1O-8-1O-4 M) on peak amylase secretion 
above basal levels in the absence (open triangles) and 
presence (solid triangles) of 10e6 M TPA. Each point is 
mean + SE, n is shown besides each point. 
amylase output in the absence (open triangles) and 
presence (solid triangles) of 10e6 M TPA. The 
dose-dependent curve obtained in the presence of 
TPA was displaced to the left, indicating the 
marked enhancement by TPA of the noradren- 
aline-induced amylase secretion. 
The effect of TPA on the ACh-evoked amylase 
secretion was also investigated. Fig.3A shows 
recordings of amylase output from a preparation 
superfused with lo-’ M ACh in the presence (a,c) 
and absence (b) of 10e6 M TPA. The mean ( + SE) 
peak increase in amylase output above basal level 
evoked by lo-’ M ACh was 4.74kO.34 unit. 
ml-’ . (100 mg tissue)-‘, n = 11. In the presence of 
1 0e6 M TPA the ACh-induced amylase output was 
2 0 ““0 Ill,- 1 
(100 m* tissue)-1 [ 
v=Y 
AChT-‘M ACh?b-IM 
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Fig.3. (A) Effects of IO-’ M ACh (acetylcholine) in the 
presence (a,c) and absence (b) of 10e6 M TPA on 
amylase release from an individual experiment. The 
horizontal bars indicate the duration of stimulation. 
Vertical calibration: 2.0 unit. ml-‘. (100 mg tissue)-‘. 
(B) Dose-dependent curves showing the effects of ACh 
(1O-9-1O-5 M) on amylase secretion in the absence (open 
triangles) and presence (solid triangles) of low6 M TPA. 
Each point is mean f SE, n is shown besides each mean 
point. 
8.66kO.46 unit-ml-‘a(100 mg tissue)-‘, n= 11. 
Fig.3B shows the effect of varying the concentra- 
tions (1O-9-1O-5 M) of ACh on amylase secretion 
in the absence (open triangles) and presence (solid 
triangles) of 10m6 M TPA. The results show that 
the phorbol ester markedly enhanced the ACh- 
elicited amylase output. 
In another series of experiments the effects of 
the Ca2+ ionophore A23187 and dibutyryl cyclic 
AMP on enzyme secretion were investigated in the 
absence and presence of TPA. Fig.4A shows a 
chart recording of amylase output from one ex- 
periment following exposure of rat pancreatic 
fragments with 1O-6 M Ca2+ ionophore A23 187 in 
the absence (a) and presence (b) of 10m6 M TPA. 
In the absence of TPA the ionophore-evoked in- 
crease in amylase secretion was 0.61 + 0.05 
unit. ml-’ . (100 mg tissue)-‘, n = 6. In the presence 
of 10e6 M TPA the ionophore-induced amylase 
193 
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Fig.4. (A) Effects of 10e6 M Ca2+ ionophore A23187 on 
amylase secretion from one single experiment in the 
absence (a) and presence (b) of 10m6 M TPA. (B) Effect 
of 5 x 10e4 M dibutyryl (DB) cyclic AMP on amylase 
output from an individual experiment in the absence (a) 
and presence (b) of 10e6 M TPA. The horizontal bars in- 
dicate the duration of stimulation. Vertical calibration: 
1.0 unit.ml-‘.(lOO mg tissue)-’ in (A) and 2.0 
units. ml-‘. (100 mg tissue)-’ in (B). 
output was 3.31 + 0.26 unit *ml-’ .(lOO mg 
tissue)-‘, n = 6. Fig.4B shows the effect of super- 
fusing a preparation with 5 x low4 M dibutyryl 
cyclic AMP in the absence (a) and presence (b) of 
low6 M TPA. Exposure of rat pancreatic frag- 
ments with 5 x 1O-4 M dibutyryl cyclic AMP 
resulted in a peak increase in amylase secretion of 
1.01+0.06 unit.ml-‘*(lo0 mg tissue)-‘, n=4. In 
the presence of 10e6 M TPA the dibutyryl cyclic 
AMP elicited amylase output was 3.96 kO.08 
unit . ml- ’ . (100 mg tissue)-‘, n = 4. The data show 
that in the continuing presence of TPA both 
dibutyryl cyclic AMP and the Ca2+ ionophore 
A23187 evoked significant (P ~0.001) increases in 
amylase secretion as compared to these substances 
in the absence of TPA. 
4. DISCUSSION 
The present study has demonstrated that the 
phorbol ester TPA alone evokes a relatively small 
increase in amylase secretion but it can markedly 
potentiate the secretory responses induced by 
noradrenaline, ACh, dibutyryl cyclic AMP and the 
Ca*+ ionophore A23187 in the isolated rat pan- 
creas. The question which now arises is: how does 
TPA act to augment the secretagogue-induced 
amylase secretion? TPA is known to stimulate en- 
zyme secretion but has no effect on either Ca*+ or 
cyclic AMP metabolism [7-91. The phorbol esters 
have been shown to exert their biological effects by 
stimulating a phospholipid and Ca*+-dependent 
protein kinase (kinase C) [10,17-201. Moreover, it 
has recently been demonstrated that the selective 
inhibitor (polymyxin B) of protein kinase C can 
completely block the TPA-induced amylase secre- 
tion in rat pancreatic acini [12]. These findings, 
taken together, would suggest hat TPA is acting 
via a different pathway, involving protein kinase 
C, to stimulate enzyme secretion. 
It has recently been shown that the noradren- 
aline-evoked amylase secretion is associated with 
an elevation in endogenous cyclic AMP [5] and it 
is also well known that the secretory action of ACh 
is associated with changes in cellular Ca*+ metabo- 
lism [21]. The combination of two secretagogues 
which are acting via two different pathways, in- 
volving both cyclic AMP and Ca*+, can markedly 
potentiate one another [6]. The present results 
have shown that TPA can enhance the secretory 
action of both noradrenaline and ACh. Moreover, 
the phorbol ester can also potentiate the secretory 
responses of the Ca*+ ionophore A23 187 and di- 
butyryl cyclic AMP, agents which are known to ar- 
tificially elevate intracellular Ca*+ and cyclic 
AMP, respectively. The most straightforward in- 
terpretation of the effect of TPA on secretagogue- 
evoked amylase secretion is to postulate that there 
is a third pathway in the pancreas by which 
secretagogues can stimulate enzyme output. This 
pathway is believed to involve protein kinase C 
(10-131, which in turn can potentiate the actions of 
pancreatic secretagogues involving either Ca*+ or 
cyclic AMP metabolism. 
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